2015
DOI: 10.1016/j.ctrsc.2015.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Three-dimensional binding sites volume assessment during cardiac pacing lead extraction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Even with current guidelines, lead extractions are not carried out as much as they could be, as one third of patients with device infections do not receive the proper lead removal therapy and only 15 % of patients with abandoned leads have these extracted in the US. 98,99 Ultimately, the goal of these new technologies is to reduce the burden of CIED complications and ensure all patients receive the appropriate intervention. To attain this vision, practitioners must remain committed to fostering a culture of both steadfast innovation and collaboration, while ensuring that safety and efficacy remain at the forefront of this exciting arena in medicine.…”
Section: Prospective Innovationmentioning
confidence: 99%
See 1 more Smart Citation
“…Even with current guidelines, lead extractions are not carried out as much as they could be, as one third of patients with device infections do not receive the proper lead removal therapy and only 15 % of patients with abandoned leads have these extracted in the US. 98,99 Ultimately, the goal of these new technologies is to reduce the burden of CIED complications and ensure all patients receive the appropriate intervention. To attain this vision, practitioners must remain committed to fostering a culture of both steadfast innovation and collaboration, while ensuring that safety and efficacy remain at the forefront of this exciting arena in medicine.…”
Section: Prospective Innovationmentioning
confidence: 99%
“…Additionally, recent advancements in 3D imaging technology (CartoSound™, Biosense Webster Inc) have allowed for real-time assessment of binding sites during transvenous lead extraction 97 . By integrating real-time, two-dimensional intracardiac echocardiography into the Carto® electroanatomic mapping system environment (Biosense Webster Inc), Nguyen et al demonstrated that this novel imaging modality yielded better visualization of binding site volume and morphology than fluoroscopy 98. Moreover, this resulted in a significantly…”
mentioning
confidence: 99%